Dashboard Market News Pricing Contact Us
Search 100,000+ stocks...
English EN
Deutsch DE Español ES
Sign Up
Log in

Medpace Holdings Inc
SWB:01P

Watchlist Manager
Medpace Holdings Inc Logo
Medpace Holdings Inc
SWB:01P
Watchlist
Price: 462 EUR -0.67% Market Closed
Market Cap: €8.2B
Write Note Create Alert Ask AI

Wall St Price Targets

01P Price Targets Summary
Medpace Holdings Inc

Wall Street analysts forecast 01P stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for 01P is 526.87 EUR with a low forecast of 328.51 EUR and a high forecast of 625.53 EUR.

01P Lowest Forecast
Wall Street Target
€328.51
-29% Downside
01P Average Forecast
Wall Street Target
€526.87
14% Upside
01P Highest Forecast
Wall Street Target
€625.53
35% Upside
Lowest Forecast
Price Target
328.51 EUR
29% Downside
Average Forecast
Price Target
526.87 EUR
14% Upside
Highest Forecast
Price Target
625.53 EUR
35% Upside
Medpace Holdings Inc Competitors:
Price Targets

Revenue
Forecast

20% / Year
Past Growth
9% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
20% / Year
Past Growth
9% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Over the last 11 years, the compound annual growth rate for Revenue has been 20%. The projected CAGR for the next 8 years is 9%.

What are analyst estimates?

Gross Profit
Forecast

17% / Year
Past Growth
9% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
17% / Year
Past Growth
9% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Over the last 11 years, the compound annual growth rate for Gross Profit has been 17%. The projected CAGR for the next 8 years is 9%.

What are analyst estimates?

Operating Income
Forecast

32% / Year
Past Growth
9% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
32% / Year
Past Growth
9% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Over the last 11 years, the compound annual growth rate for Operating Income has been 32%. The projected CAGR for the next 8 years is 9%.

What are analyst estimates?

Pre-Tax Income
Forecast

N/A
Past Growth
12% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
N/A
Past Growth
12% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

The compound annual growth rate for Pre-Tax Income over the next 3 years is 12%.

What are analyst estimates?

Net Income
Forecast

N/A
Past Growth
9% / Year
Estimated Growth
Estimates Accuracy
0%
Average Beat
N/A
Past Growth
9% / Year
Estimated Growth
Estimates Accuracy
0%
Average Beat

The compound annual growth rate for Net Income over the next 8 years is 9%.

What are analyst estimates?

Continue 01P Research

Summary
01P intrinsic value, competitors valuation, and company profile.
DCF Valuation
01P stock valuation using Discount Cash Flow valuation method.
Relative Valuation
01P stock valuation using valuation multiples.
Wall St Estimates
01P price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
01P stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financials
Discount Rate
Other Medpace Holdings Inc listings:
NASDAQ • USD
MEDP
 F • EUR
01P
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is 01P's stock price target?
Price Target
526.87 EUR

According to Wall Street analysts, the average 1-year price target for 01P is 526.87 EUR with a low forecast of 328.51 EUR and a high forecast of 625.53 EUR.

What is the Revenue forecast for Medpace Holdings Inc?
Projected CAGR
9%

Over the last 11 years, the compound annual growth rate for Revenue has been 20%. The projected CAGR for the next 8 years is 9%.

What is the Gross Profit forecast for Medpace Holdings Inc?
Projected CAGR
9%

Over the last 11 years, the compound annual growth rate for Gross Profit has been 17%. The projected CAGR for the next 8 years is 9%.

What is the Operating Income forecast for Medpace Holdings Inc?
Projected CAGR
9%

Over the last 11 years, the compound annual growth rate for Operating Income has been 32%. The projected CAGR for the next 8 years is 9%.

What is the Pre-Tax Income forecast for Medpace Holdings Inc?
Projected CAGR
12%

The compound annual growth rate for Pre-Tax Income over the next 3 years is 12%.

What is the Net Income forecast for Medpace Holdings Inc?
Projected CAGR
9%

The compound annual growth rate for Net Income over the next 8 years is 9%.

Back to Top
ALPHA SPREAD
Follow us
Join 358,400+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Valuation Backtest Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.